FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281295781> ?p ?o ?g. }

• W4281295781 endingPage "4760" @default.
• W4281295781 startingPage "4737" @default.
• W4281295781 abstract "Metabolic reprogramming is a feature of tumour cells and is essential to support their rapid proliferation. The glycolytic activity of liver cancer cells is significantly higher than that of normal liver cells, and the rapidly proliferating tumour cells are powered by aerobic glycolysis. Lipid metabolism reprogramming enables tumour cells to meet their needs for highly proliferative growth and is an important driving force for the development of hepatocellular carcinoma (HCC).To explore the influence of different metabolic subtypes of HCC and analyse their significance in guiding prognosis and treatment based on the molecular mechanism of glycolysis and fatty acid oxidation (FAO).By downloading related data from public databases including the Cancer Genome Atlas (TCGA), the Molecular Signatures Database, and International Cancer Genome Consortium, we utilised unsupervised consensus clustering to divide TCGA Liver Hepatocellular Carcinoma samples into four metabolic subgroups and compared single nucleotide polymorphism, copy number variation, tumour microenvironment, and Genomics of Drug Sensitivity in Cancer and Tumour Immune Dysfunction and Exclusion between different metabolites. The differences and causes of survival and the clinical characteristics between them were analysed, and a prognostic model was established based on glycolysis and FAO genes. Combined with the clinical features, a Norman diagram was created to compare the pros and cons of each model.In the four metabolic subgroups, with the increase in glycolytic expression, the median survival of patients showed the worst results, while FAO showed the best. When comparing the follow-up analysis of each group, we considered that the differences between them might be related to reactive oxygen species, somatic copy number variation of key genes, and immune microenvironment. It was also found that the FAO group and the low-risk group had better efficacy and response to immune checkpoint blockade treatment and anti-tumour drugs.There are obvious differences in genes, chromosomes, and clinical characteristics between metabolic subgroups. The establishment of a prognostic model could predict patient prognosis and guide clinical treatment." @default.
• W4281295781 created "2022-05-24" @default.
• W4281295781 creator A5036439714 @default.
• W4281295781 creator A5051948832 @default.
• W4281295781 creator A5059905832 @default.
• W4281295781 creator A5068522074 @default.
• W4281295781 creator A5075834065 @default.
• W4281295781 date "2022-05-26" @default.
• W4281295781 modified "2023-10-14" @default.
• W4281295781 title "Glycolytic and fatty acid oxidation genes affect the treatment and prognosis of liver cancer" @default.
• W4281295781 cites W1528671482 @default.
• W4281295781 cites W1968075505 @default.
• W4281295781 cites W1975701262 @default.
• W4281295781 cites W1980568044 @default.
• W4281295781 cites W2004507031 @default.
• W4281295781 cites W2014211689 @default.
• W4281295781 cites W2041608387 @default.
• W4281295781 cites W2048899027 @default.
• W4281295781 cites W2064070262 @default.
• W4281295781 cites W2068127752 @default.
• W4281295781 cites W2078940386 @default.
• W4281295781 cites W2087358801 @default.
• W4281295781 cites W2097259163 @default.
• W4281295781 cites W2136415416 @default.
• W4281295781 cites W2162790428 @default.
• W4281295781 cites W2168277151 @default.
• W4281295781 cites W2168919362 @default.
• W4281295781 cites W2173418347 @default.
• W4281295781 cites W2518685627 @default.
• W4281295781 cites W2556091772 @default.
• W4281295781 cites W2561459036 @default.
• W4281295781 cites W2562523962 @default.
• W4281295781 cites W2594430933 @default.
• W4281295781 cites W2601094294 @default.
• W4281295781 cites W2605757478 @default.
• W4281295781 cites W2606175565 @default.
• W4281295781 cites W2607640564 @default.
• W4281295781 cites W2612207404 @default.
• W4281295781 cites W2753473515 @default.
• W4281295781 cites W2902060903 @default.
• W4281295781 cites W2914525558 @default.
• W4281295781 cites W2972983974 @default.
• W4281295781 cites W2999496800 @default.
• W4281295781 cites W3004414073 @default.
• W4281295781 cites W3030728390 @default.
• W4281295781 cites W3160918506 @default.
• W4281295781 doi "https://doi.org/10.12998/wjcc.v10.i15.4737" @default.
• W4281295781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35801051" @default.
• W4281295781 hasPublicationYear "2022" @default.
• W4281295781 type Work @default.
• W4281295781 citedByCount "0" @default.
• W4281295781 crossrefType "journal-article" @default.
• W4281295781 hasAuthorship W4281295781A5036439714 @default.
• W4281295781 hasAuthorship W4281295781A5051948832 @default.
• W4281295781 hasAuthorship W4281295781A5059905832 @default.
• W4281295781 hasAuthorship W4281295781A5068522074 @default.
• W4281295781 hasAuthorship W4281295781A5075834065 @default.
• W4281295781 hasBestOaLocation W42812957811 @default.
• W4281295781 hasConcept C104317684 @default.
• W4281295781 hasConcept C121608353 @default.
• W4281295781 hasConcept C126322002 @default.
• W4281295781 hasConcept C150194340 @default.
• W4281295781 hasConcept C162317418 @default.
• W4281295781 hasConcept C20251656 @default.
• W4281295781 hasConcept C2776231280 @default.
• W4281295781 hasConcept C2778019345 @default.
• W4281295781 hasConcept C502942594 @default.
• W4281295781 hasConcept C54355233 @default.
• W4281295781 hasConcept C55885012 @default.
• W4281295781 hasConcept C60644358 @default.
• W4281295781 hasConcept C62231903 @default.
• W4281295781 hasConcept C71924100 @default.
• W4281295781 hasConcept C86803240 @default.
• W4281295781 hasConceptScore W4281295781C104317684 @default.
• W4281295781 hasConceptScore W4281295781C121608353 @default.
• W4281295781 hasConceptScore W4281295781C126322002 @default.
• W4281295781 hasConceptScore W4281295781C150194340 @default.
• W4281295781 hasConceptScore W4281295781C162317418 @default.
• W4281295781 hasConceptScore W4281295781C20251656 @default.
• W4281295781 hasConceptScore W4281295781C2776231280 @default.
• W4281295781 hasConceptScore W4281295781C2778019345 @default.
• W4281295781 hasConceptScore W4281295781C502942594 @default.
• W4281295781 hasConceptScore W4281295781C54355233 @default.
• W4281295781 hasConceptScore W4281295781C55885012 @default.
• W4281295781 hasConceptScore W4281295781C60644358 @default.
• W4281295781 hasConceptScore W4281295781C62231903 @default.
• W4281295781 hasConceptScore W4281295781C71924100 @default.
• W4281295781 hasConceptScore W4281295781C86803240 @default.
• W4281295781 hasIssue "15" @default.
• W4281295781 hasLocation W42812957811 @default.
• W4281295781 hasLocation W42812957812 @default.
• W4281295781 hasLocation W42812957813 @default.
• W4281295781 hasOpenAccess W4281295781 @default.
• W4281295781 hasPrimaryLocation W42812957811 @default.
• W4281295781 hasRelatedWork W2020483997 @default.
• W4281295781 hasRelatedWork W2098664416 @default.
• W4281295781 hasRelatedWork W2133154786 @default.
• W4281295781 hasRelatedWork W2186302778 @default.

• next